Through the genome-wide expression microarray analysis of recurrent HCC, it is found that NUF2 complicated with liver cirrhosis can be used as a promising prognostic biomarker of early HCC recurrence [23]. This evidence concerns the gene NUF2 and cirrhosis of liver.